BRN.AX BrainChip Holdings Ltd A$0.135 pre-market 24 Feb 2026: AI stock outlook

BRN.AX stock opens pre-market at A$0.135 on 24 Feb 2026, trading on the ASX with volume 3,668,536.00 so far. BrainChip Holdings Ltd (BRN.AX) develops the Akida neuromorphic processor for low-power edge AI. The company reports EPS -0.02 and PE -6.75, with market cap A$318,391,868.00. Investors watch the 2026-03-04 earnings date for revenue updates and contract progress.

BRN.AX stock: Pre-market snapshot and technicals

Pre-market price is A$0.135 with a day range A$0.135–A$0.140. Volume stands at 3,668,536.00, below the 50-day average of 9,055,140.00. Technicals show RSI 36.42 and ADX 36.56, indicating a firm downtrend and room for short-term oversold moves.

BRN.AX stock: Fundamentals and valuation

BrainChip (BRN.AX) is listed on the ASX in Australia with EPS -0.02 and PE -6.75. Key ratios include PB 13.05 and current ratio 5.18, showing liquidity strength but high valuation metrics. Revenue per share is 0.00063 and book value per share is 0.00733, reflecting early-stage semiconductor economics.

BRN.AX stock: Meyka AI grade and model forecast

Meyka AI rates BRN.AX with a score out of 100. Meyka AI rates BRN.AX with a score of 64.71 out of 100 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects A$0.15107 for one year, an implied upside of 11.91% versus the current A$0.135. Forecasts are model-based projections and not guarantees.

BRN.AX stock: Catalysts, earnings and risks

Upcoming catalysts include the earnings release on 2026-03-04 and customer pilots for Akida SoC in automotive and cybersecurity applications. Fiscal progress in revenue or a major design win would lift sentiment. Risks include stretched valuation, negative net income margins of -16.94%, and reliance on edge-AI adoption.

BRN.AX stock: Trading flow, liquidity and sector context

Liquidity has slowed: average volume 9,055,140.00 versus current 3,668,536.00, raising execution risk for large orders. The Technology sector on the ASX shows a 3-month performance of -11.12%, pressuring small-cap AI hardware names. BrainChip sits in Semiconductors, where investor focus is on revenue traction and margin expansion.

BRN.AX stock: Short-term strategy and price targets

Short-term traders may look for support at the year low A$0.130 and resistance near the 50-day average A$0.166. Meyka scenarios: conservative target A$0.110, base target A$0.151, and optimistic target A$0.280 using year high context A$0.320. Position sizing should reflect high volatility and small-cap risk.

Final Thoughts

Key takeaways for BRN.AX stock in the ASX pre-market are clear. BrainChip trades at A$0.135 with a lean liquidity profile and elevated valuation ratios like PB 13.05 and PE -6.75. The next earnings release on 2026-03-04 is the primary catalyst for re-rating. Meyka AI’s forecast model projects A$0.15107 in one year, implying an upside of 11.91% from today. That projection sits against a realistic downside to the year low A$0.130, so risk-reward is asymmetric for short-term traders. Our Meyka grade of 64.71 (B, HOLD) reflects mixed signals: strong liquidity buffers but limited current revenue and negative margins. For investors focused on AI hardware, watch contract rollouts and margin trends. Meyka AI provides this analysis as an AI-powered market analysis platform; forecasts and grades are model outputs, not investment advice. Sources: company filings and public social updates

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.